Bio Techne reported $51.05M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD -527.1M 1.25B Mar/2026
Bruker USD -62.9M 66.4M Jun/2026
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Danaher USD 870M 159M Jun/2026
Illumina USD 207M 73M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Merck EUR 659M 340M Mar/2026
Mettler Toledo International USD 232.9M 63.44M Jun/2026
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Repligen USD 5.01M 3.32M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
Standard Biotools USD 127.07M 107.78M Mar/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Waters USD -72M 297.21M Mar/2026